Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditMass drug administration for malariaMalarial pathocoenosis: beneficial and deleterious interactions between malaria and other human diseasesMalaria in school-age children in Africa: an increasingly important challengeIntermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, UgandaCost analysis of school-based intermittent screening and treatment of malaria in KenyaMalaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity.The end of a dogma: the safety of doxycycline use in young children for malaria treatment.Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishmentsEffects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in MaliRandomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina FasoRethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.Plasmodium infection, anaemia and mosquito net use among school children across different settings in KenyaEfficacy and safety of intermittent preventive treatment for malaria in schoolchildren: a systematic review.Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.Asymptomatic Plasmodium infection and cognition among primary schoolchildren in a high malaria transmission setting in Uganda.Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.Analysis of the causes of spawning of large-scale, severe malarial epidemics and their rapid total extinction in western Provence, historically a highly endemic region of France (1745-1850)Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.Impact of a malaria intervention package in schools on Plasmodium infection, anaemia and cognitive function in schoolchildren in Mali: a pragmatic cluster-randomised trial.Pilot Study of the Addition of Mass Treatment for Malaria to Existing School-Based Programs to Treat Neglected Tropical Diseases.Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System.School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali.
P2860
Q21032449-FEFABE1D-1C5E-46AC-8044-BD24BC72CE4FQ24201881-4E780D02-20EB-488F-A66F-08B7C44DDDA2Q26852628-FC49586B-7B46-42F8-9E5F-2D88C7ED51A5Q26858829-03F4CAD9-DA2D-46E9-A7BA-B7140DA07E2AQ28536733-5C67DCAC-DC29-485D-96DE-70813FFA7FD1Q28744234-F06DD8AB-006A-4A5D-A3B0-5E87BBDDFCAFQ30226671-1A3A407E-FFE2-4150-8373-8C686E162EC3Q30245481-05D25101-4606-49EA-B56D-9FB4D26C7A23Q33560396-A645C78C-DD77-4920-8D08-890E955ABE53Q33589334-1B41DF06-8DC7-4B5F-8E82-D7C3722E0328Q35215367-61A2B7BD-4574-41D7-80FD-CB72E34EF83AQ35398338-75E3E400-A42C-421A-94B2-25FF3C46E48BQ35859844-6980A5E3-B6F7-4FC4-B1B0-72A12F78E2FFQ36018444-8F7FCF88-2DF3-4458-98F0-F8C3B03D5C61Q36094714-C11D2FA9-6C52-4673-BC70-F3CE3864C146Q36195856-1CF24074-4F7B-45D0-B99A-9A5DD6CE49BAQ36286159-18E162F7-6FA5-4F15-9193-C8471D3F6215Q37077284-8D937119-FCDA-4494-96E3-B3887A12515FQ37119552-79902726-6CEC-4619-93C2-53A3B1192D71Q37287899-79D4C596-82DD-4400-A0A7-BFDB02DBC994Q37524994-1102B6B0-171A-457E-9501-77374FEF2CD2Q37612497-10E1CF8D-D656-42E9-B444-F507D7F0BA56Q37726083-2A52AD0A-AAA4-4EBA-958F-75DFB1C652C3Q38642887-1A5959E4-4B23-40C6-BEA9-A14741670B10Q38905356-CC5EFF5C-E822-4753-ADB8-211AC7D406BDQ41947692-8A3440F7-CE6C-4BE6-9441-BA20630B10FFQ42632851-14671F0E-38B6-43E1-90D1-882BC047DBA9Q46856648-635DE28F-F6EC-4C87-B095-7B8F690105D3Q55410478-8E51106C-E358-4143-A92D-6EC335447EDCQ55477044-75FA5632-E6D0-46DA-8CF2-0148E0D3615B
P2860
Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@ast
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en-gb
type
label
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@ast
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en-gb
prefLabel
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@ast
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en-gb
P2093
P2860
P50
P921
P1433
P1476
Efficacy, safety, and tolerabi ...... ial in Ugandan schoolchildren.
@en
P2093
Joaniter Nankabirwa
Narcis Kabatereine
Sian Clarke
Simon Brooker
P2860
P304
P356
10.1371/JOURNAL.PONE.0013438
P407
P577
2010-10-19T00:00:00Z